Management Options for Hot Flushes
For hot flushes management, first-line pharmacological options include SNRIs (particularly venlafaxine), SSRIs, gabapentin, and lifestyle modifications, with treatment selection based on symptom severity, comorbidities, and patient preference. 1, 2
Pharmacological Management
First-Line Options
SNRIs/SSRIs
- Venlafaxine: 75 mg/day (first-line), reduces hot flash scores by 61% compared to placebo 2
- Paroxetine: 7.5 mg daily (caution with tamoxifen due to CYP2D6 inhibition) 1, 2
- Citalopram/Fluoxetine/Sertraline: Alternative options with variable efficacy 2
- Side effects: Nausea, dry mouth, decreased appetite, constipation, sexual dysfunction 1
- Important note: Taper gradually when discontinuing to prevent withdrawal symptoms 1
Anticonvulsants
- Gabapentin: Start at 300mg at bedtime, gradually increase to 900mg/day (reduces hot flashes by 51% vs 26% with placebo) 1, 2
- Particularly useful: For patients with sleep disturbances due to somnolence side effect 1
- Advantages: No known drug interactions, no sexual dysfunction, no withdrawal syndrome 2
Antihypertensives
Comparative Efficacy
- Venlafaxine works faster but is less well tolerated than clonidine 1
- In crossover studies, 68% of patients preferred venlafaxine over gabapentin despite similar efficacy in reducing hot flash severity 1
Non-Pharmacological Management
Lifestyle Modifications
Complementary Approaches
Other Options
- Yoga: May improve quality of life associated with menopause 1
- Phytoestrogens/botanicals/supplements: Mixed or limited evidence (category 2B recommendation) 1
- Vitamin E: Marginal improvement but mixed results 1
- Black cohosh: Possible benefit in general population but no benefit shown in breast cancer survivors 1
Special Considerations
For Cancer Survivors
- Avoid paroxetine in patients on tamoxifen due to CYP2D6 inhibition 1, 2
- Preferred options: Venlafaxine, gabapentin, clonidine 1
- Avoid systemic hormone therapy in breast cancer survivors 1
- For vaginal symptoms, use non-hormonal moisturizers and lubricants 2
For Patients with Aromatase Inhibitors
- Higher incidence of vaginal dryness compared to tamoxifen users 2
- Avoid estradiol preparations as they may increase circulating estradiol levels 2
- Consider estriol-containing preparations as they cannot convert to estradiol 2
For Patients with Sleep Disturbances
Treatment Algorithm
Initial Assessment:
- Determine severity of symptoms
- Screen for contraindications to medication options
- Evaluate cardiovascular risk factors 2
First-Line Treatment:
- For mild symptoms: Start with lifestyle modifications
- For moderate to severe symptoms: Add pharmacological therapy based on comorbidities:
- If sleep disturbance predominant: Gabapentin
- If mood symptoms present: SNRI/SSRI (venlafaxine preferred)
- If hypertensive: Consider clonidine
Follow-up at 4 weeks:
Long-term Management:
- Periodically reassess need for continued therapy
- For SNRIs/SSRIs: Ensure gradual tapering when discontinuing 1
Pitfalls and Caveats
- Hormone replacement therapy carries significant risks (stroke, DVT, PE, MI, breast cancer) and should be avoided or used with extreme caution 2
- Immersion in ice or cold water should be limited (e.g., 10 minutes, 4 times daily) to prevent tissue damage 1
- Powerful fans near extremities can lead to equivalent of windburn 1
- SSRIs that inhibit CYP2D6 (e.g., paroxetine) may reduce conversion of tamoxifen to active metabolites 1
By following this structured approach to hot flush management, clinicians can effectively address this common and distressing symptom while minimizing risks and side effects.